Mesenchymal stem cell isolation from human umbilical cord tissue: Understanding and minimizing variability in cell yield for process optimization

Biopreservation and Biobanking

Volumn 11, Issue 5, 2013, Pages 291-298

  Iftimia Mander, Andreea ^a   Hourd, Paul ^a   Dainty, Roger ^b   Thomas, Robert J ^a  

^a LOUGHBOROUGH UNIVERSITY   (United Kingdom)

^b Future Health Technologies   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL POPULATION; CELL PROLIFERATION; EXTRACTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROCESS OPTIMIZATION; TISSUE PRESERVATION; UMBILICAL CORD; CELL SEPARATION; CYTOLOGY; MESENCHYMAL STROMA CELL; METABOLISM; NEWBORN; PROCEDURES;

BIOLOGICAL MARKER;

BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; HUMANS; INFANT, NEWBORN; MESENCHYMAL STROMAL CELLS; TISSUE PRESERVATION; UMBILICAL CORD;

EID: 84885917682     PISSN: 19475535     EISSN: 19475543     Source Type: Journal    
DOI: 10.1089/bio.2013.0027     Document Type: Article

References (20)

1. Deans RJ, Moesley AB Mesenchymal stem cells: biology and potential clinical use. Exp. Hematol 2000;28:875-884.
2. Motaln H, et al. Human mesenchymal stem cells and their use in cell-based therapies. Cancer 2010;116:2519-2530.
3. Young HE, Black AC Adult stem cells. Anat Rec A Discov Mol Cell Evol Biol.2004;276:75-102.
4. Fan CG, Zhang Q, Zhou J. Therapeutic potentials of mesenchy-mal stem cells derived from human umbilical cord. Stem Cell Rev and Rep 2011:7:195-207.
5. Troyer DL, Weiss ML. Wharton's jelly-derived stromal cells. Stem Cells 2008;26:591-599.
6. Karahuseyinoglu S et al. Biology of stem cells in human umbilical cord stroma: In situ and in vitro surveys. Stem Cells 2007; 25:319-331.
7. Majore I et al. Identification of subpopulations in mesenchymal stem cell-like cultures from human umbilical cord. Cell Commun Sign 2009;7:6.
8. Can A, Karahuseyinoglu S. Concise review: Human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells 2007;25:2886-2895.
9. Baksh D, Yao R, Tuan RS. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 2007;25:1384-1392.
10. Weiss ML et al. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 2007;24:781-792.
11. Bailey MM et al. A comparison of human umbilical cord matrix stem cells and temporomandibular joint condylar chondrocytes for tissue engineering temporomandibular joint condylar cartilage. Tissue Eng 2007;13:2003-2010.
12. Lu LL et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 2006;91:1017-1026.
13. Mitchell KE et al. Matrix cells from Wharton's jelly form neurons and glia. Stem Cells 2003;21:50-60.
14. Wang HS et al. Mesnchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 2004;22:1330-1337.
15. Lund RD et al. Cells isolated from umbilical cord tissue rescue photoreceptors and visual functions in a rodent model of retinal disease. Stem Cells 2007;25:602-611.
16. Petsa A et al. Effectiveness of protocol for the isolation of Wharton's jelly stem cells in large-scale applications. In Vitro Cell Dev Biol Anim 2009;45:573-576.
17. Qiao C et al. Human mesenchymal stem cells isolated from the umbilical cord. Cell Biol. Int. 2008;32:8-15.
18. Wagner W et al. Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One 2008; 3:2213.
19. Cheng H et al. Replicative senescence of human bone marrow and umbilical cord derived mesenchymal stem cells and their differentiation to adipocytes and osteoblasts. Mol Biol Rep. 2011; 38:5161-5168.
20. Rathore AS, Winkle H. Quality by design for biopharmaceu-ticals. Nature Biotechnology 2009;27:26-34.